Ahn Y - Search Results

1

Ezetimibe and Rosuvastatin Combination Treatment Can Reduce the Dose of Rosuvastatin Without Compromising Its Lipid-lowering Efficacy.

Rhee MY, Kim KJ, Kim SH, Yoon YW, Rha SW, Hong SJ, Kwak CH, Kim W, Nam CW, Park TH, Hong TJ, Park S, Ahn Y, Lee N, Jeon HK, Jeon DW, Han KR, Moon KW, Chae IH, Kim HY, Kim HS. Rhee MY, et al. Among authors: ahn y. Clin Ther. 2019 Dec;41(12):2571-2592. doi: 10.1016/j.clinthera.2019.10.010. Epub 2019 Nov 11. Clin Ther. 2019. PMID: 31727361 Clinical Trial.

2

Elevated preprocedural high-sensitivity C-reactive protein levels are associated with neointimal hyperplasia and restenosis development after successful coronary artery stenting.

Hong YJ, Jeong MH, Lim SY, Lee SR, Kim KH, Sohn IS, Park HW, Kim JH, Kim W, Ahn Y, Cho JG, Park JC, Kang JC. Hong YJ, et al. Among authors: ahn y. Circ J. 2005 Dec;69(12):1477-83. doi: 10.1253/circj.69.1477. Circ J. 2005. PMID: 16308495 Free article.

3

Preinterventional peak monocyte count and in-stent intimal hyperplasia after coronary stent implantation in human coronary arteries.

Hong YJ, Jeong MH, Lim SY, Lee SR, Kim KH, Sohn IS, Park HW, Kim JH, Kim W, Ahn Y, Cho JG, Park JC, Kang JC. Hong YJ, et al. Among authors: ahn y. Clin Cardiol. 2005 Nov;28(11):512-8. doi: 10.1002/clc.4960281105. Clin Cardiol. 2005. PMID: 16450794 Free PMC article.

4

Relation of soft plaque and elevated preprocedural high-sensitivity C-reactive protein levels to incidence of in-stent restenosis after successful coronary artery stenting.

Hong YJ, Jeong MH, Lim SY, Lee SR, Hong SN, Kim KH, Sohn IS, Park HW, Kim JH, Kim W, Ahn Y, Cho JG, Park JC, Kang JC. Hong YJ, et al. Among authors: ahn y. Am J Cardiol. 2006 Aug 1;98(3):341-5. doi: 10.1016/j.amjcard.2006.02.037. Epub 2006 Jun 12. Am J Cardiol. 2006. PMID: 16860020

5

Rosuvastatin suppresses the inflammatory responses through inhibition of c-Jun N-terminal kinase and Nuclear Factor-kappaB in endothelial cells.

Kim YS, Ahn Y, Hong MH, Kim KH, Park HW, Hong YJ, Kim JH, Kim W, Jeong MH, Cho JG, Park JC, Kang JC. Kim YS, et al. Among authors: ahn y. J Cardiovasc Pharmacol. 2007 Jun;49(6):376-83. doi: 10.1097/FJC.0b013e31804a5e34. J Cardiovasc Pharmacol. 2007. PMID: 17577102

6

Anti-inflammatory effect of abciximab-coated stent in a porcine coronary restenosis model.

Hong YJ, Jeong MH, Lee SR, Hong SN, Kim KH, Park HW, Kim JH, Kim W, Ahn Y, Cho JG, Park JC, Kang JC. Hong YJ, et al. Among authors: ahn y. J Korean Med Sci. 2007 Oct;22(5):802-9. doi: 10.3346/jkms.2007.22.5.802. J Korean Med Sci. 2007. PMID: 17982226 Free PMC article.

7

Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.

Kim SH, Kim YD, Lim DS, Yoon MH, Ahn YK, On YK, Lee JW, Kim IJ, Park JB, Kim JJ, Chung WS, Yang JY, Seo HS, Shin EK, Kim HS; Korean Multicenter Amlodipine Study Investigators. Kim SH, et al. Clin Ther. 2007 Sep;29(9):1924-36. doi: 10.1016/j.clinthera.2007.09.018. Clin Ther. 2007. PMID: 18035192 Clinical Trial.

8

Randomized comparison of cilostazol vs clopidogrel after drug-eluting stenting in diabetic patients--clilostazol for diabetic patients in drug-eluting stent (CIDES) trial.

Ahn Y, Jeong MH, Jeong JW, Kim KH, Ahn TH, Kang WC, Park CG, Kim JH, Chae IH, Nam CW, Hur SH, Bae JH, Kim KY, Oh SK. Ahn Y, et al. Among authors: ahn th. Circ J. 2008 Jan;72(1):35-9. doi: 10.1253/circj.72.35. Circ J. 2008. PMID: 18159096 Free article. Clinical Trial.

9

Inflammation and delayed endothelization with overlapping drug-eluting stents in a porcine model of in-stent restenosis.

Lim SY, Jeong MH, Hong SJ, Lim DS, Moon JY, Hong YJ, Kim JH, Ahn Y, Kang JC. Lim SY, et al. Among authors: ahn y. Circ J. 2008 Mar;72(3):463-8. doi: 10.1253/circj.72.463. Circ J. 2008. PMID: 18296847 Free article.

10

A multicenter, randomized, open-label, therapeutic, and exploratory trial to evaluate the tolerability and efficacy of platelet glycoprotein IIb/IIIa receptor blocker (Clotinab) in high-risk patients with percutaneous coronary intervention.

Moon JY, Kim W, Kim JH, Ahn Y, Jeong MH, Kim YH, Hong MK, Park SW, Park SJ, Park S, Ko YG, Choi D, Jang Y. Moon JY, et al. Among authors: ahn y. Yonsei Med J. 2008 Jun 30;49(3):389-99. doi: 10.3349/ymj.2008.49.3.389. Yonsei Med J. 2008. PMID: 18581587 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,327 results

Search Page